CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $403,975
- in 4 filings, $404K under 10b5-1 plans
Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-18 | Hoitt Jason Chief Patient Officer | Sale | −1,762 | $31.28 | $55K | 10,445 |
| 2026-03-18 | Hoitt Jason Chief Patient Officer | Sale | −139 | $31.79 | $4K | 10,306 |
| 2026-03-18 | Hoitt Jason Chief Patient Officer | Sale | −30 | $32.85 | $986 | 10,276 |
| 2026-03-17 | Hoitt Jason Chief Patient Officer | Sale | −1,033 | $32.74 | $34K | 12,955 |
| 2026-03-17 | Hoitt Jason Chief Patient Officer | Sale | −748 | $33.38 | $25K | 12,207 |
| 2026-03-15 | Hoitt Jason Chief Patient Officer | Option exercise | +10,000 | 13,988 | ||
| 2026-03-15 | Hoitt Jason Chief Patient Officer | Option exercise · Restricted Stock Units | −10,000 | 30,000 | ||
| 2026-02-17 | Hoitt Jason Chief Patient Officer | Grant or award · Employee Stock Option (Right to Buy) | +72,000 | 72,000 | ||
| 2026-02-17 | Hoitt Jason Chief Patient Officer | Grant or award · Restricted Stock Units | +48,000 | 48,000 |
Page 1 of 1 · 9 trades